The Business Of Venture Capital

What You Actually Do When You Run A VC Firm

The Business Of Venture Capital is mostly about allocation decisions that will look right or wrong depending on when you check back. Most people who read about VCs picture deal rooms and term sheets. That is the visible layer. The actual work happens three years before the check writes and two years after portfolio companies report their first real problems. I spent years on the investing side and then moved into advisory work. What I learned is that venture capital firms are fundamentally probability engines. Your returns depend on running enough shots at the wall while ensuring each shot has asymmetric upside. The math does not forgive laziness. A fund with twelve investments where every company returns under one times capital will not survive to year five. The ones that survive are usually the ones that cut the noise early and doubled down on the signals they missed initially. Fundraising is the first and most underrated function. LP money comes with terms. Good terms mean quiet. Bad terms mean you will be answering the same questions for seven years. I have watched first-time fund managers waste eighteen months chasing commitments from family offices that required board seats and veto rights over individual deals. Those deals kill your ability to syndicate. Walk away from those LPs. The money is not worth the handcuffs.

Deal sourcing follows a different pattern than people expect. Inbound interest from founders is real, but the quality drops off sharply after the first fifty pitches. The best deals come through operator networks, not LinkedIn. I started keeping a simple spreadsheet of engineers and product leads who had sold companies in the last three years. Thirty percent of my subsequent fund returns came from cold outreach to people in that list. You do not get those names from a CRM.

Term Sheets And What They Actually Cost You

Term sheets look like legal documents. They are negotiation instruments. The economics matter less than the control provisions in most cases. I see founders obsess over valuation and then give away participation rights, liquidation preferences stacked above one times, and broad-based anti-dilution that survives subsequent down rounds. A twenty million dollar pre-money valuation means nothing if the instrument converts into participation preferred and the company eventually exits for twenty-five million. One practical rule I use: if a term sheet includes drag-along rights below a threshold price, ask for a fallback. Without a fallback, a majority investor can force a sale at a price that leaves minorities empty. I had a portfolio company where the lead investor triggered drag along at four million dollars because a strategic buyer offered cash and the fund needed liquidity before their next fund lifecycle. The founders walked away with nothing. The minority investors lost their entire positions. That deal was recorded as a write-off in the annual report and nobody discussed it at the partners meeting. It happens more often than you would think.

Board Seats And When They Are A Liability

Taking board seats is where VCs get busy. Most funds do not have enough experienced operators to staff every seat well. I once sat on a board for a climate tech company where the CEO had no supply chain experience and we had none either. We spent six months trying to fix vendor contracts that required industry knowledge we did not possess. The workaround was simple in hindsight. We brought in a paid advisor from the logistics space on a twenty thousand dollar per month retainer. That fixed the problem in eight weeks and cost far less than the dilution the company took from a bridge round to keep operating. Board meetings should follow a strict agenda. Most founders and investors ignore this and end up spending ninety minutes on operational details that should go to committee or advisory calls. I started requiring a pre-read document thirty-six hours before every board meeting. If it was not in the pre-read, it was not discussed. This reduced average board meeting time from two hours to forty-five minutes and forced the team to prioritize what actually mattered.

Portfolio Construction And The Power Law

Venture returns follow a power law. The top one or two companies in a fund typically generate eighty to ninety percent of total returns. This means your initial thesis about which companies will succeed is usually wrong. The job is to identify the winners early enough to increase your ownership through follow-on participation. Most funds fail here because they let fear override the thesis. When a portfolio company misses its next milestone, the knee-jerk reaction is to reduce exposure. The correct reaction is to investigate whether the miss is structural or temporary. I kept a decision log for every portfolio company. Each entry recorded the original thesis, the observed variance, and the action taken. Reviewing that log quarterly showed me where my bias toward conservatism was costing returns. After the second year, I stopped down-sizing positions on companies that missed short-term targets unless the revenue model itself was compromised. The companies that missed targets but kept growing revenue outperformed the companies that hit targets and plateaued.

Exit Timing And The Illusion Of Control

Exits are timed by market conditions, not by your satisfaction. I have seen partners delay exits by eighteen months because they wanted one more point of growth. The market moved. The acquirer changed strategy. The company got acquired for less than the prior offer. That is the reality of venture exits. You do not control them. You control your preparation. Data rooms should be maintained continuously, not assembled during diligence. I required every portfolio company to update their cap table, IP assignments, and key contracts monthly. When diligence started, most teams could produce a clean data room in two days instead of the usual three weeks. This alone made our funds more attractive to acquirers and reduced the probability of deals falling apart due to discovery surprises.

What This Approach Misses

The methods described above work for late seed through series B investments in software and hardware companies. They do not translate well to venture debt, venture philanthropy, or sector-specific funds like biotech where regulatory timelines dominate every decision. If you are running a fund focused on pre-seed or seed stage, the board seat strategy shifts significantly because most companies at that stage cannot absorb the overhead of active governance. You would need to rely more on observer rights and advisory relationships instead. The spreadsheet approach for sourcing also loses effectiveness after about two hundred names, at which point the marginal return on outreach drops below the cost of the time spent managing relationships. The biggest bottleneck in this model is partner bandwidth. No single person can meaningfully oversee more than eight to ten active board seats without the quality of oversight degrading. Funds that scale beyond that range without adding senior operators hit diminishing returns on portfolio support. The workaround is to rotate board seats or use a syndicate model where responsibility is shared across partners with complementary expertise. I have also seen funds outperform by intentionally capping their active positions at six to eight and letting the rest of the portfolio run through passive follow-on rights rather than active involvement.